| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,842 | 2,684 | 2,934 | 7,921 | | Cost of Revenue | 942 | 1,213 | 1,345 | 4,085 | | | Gross Profit | 900 | 1,471 | 1,589 | 3,836 | | | Operating Expenses | | Research Development | 642 | 691 | 689 | 792 | | Selling General and Administrative | 3,644 | 3,764 | 4,211 | 4,311 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,386) | (2,984) | (3,311) | (1,267) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 393 | 703 | 239 | 35 | | Earnings Before Interest And Taxes | (2,993) | (2,281) | (3,072) | (1,232) | | Interest Expense | 44 | 43 |
-
|
-
| | Income Before Tax | (3,037) | (2,324) | (3,072) | (1,232) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,037) | (2,324) | (3,072) | (1,232) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,037) | (2,324) | (3,072) | (1,232) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,037) | ($2,324) | ($3,072) | ($1,232) |
|
0.51% Nasdaq 
Income Statement
